Freelite®

Freelite aids the detection and monitoring of Multiple Myeloma and related diseases

Freelite assays show excellent precision and reproducibility to give you confidence in the consistency of each reagent batch. Freelite assay precision is tested by following strict CLSI guidelines.

An independent study gave the following results for Freelite reproducibility based on ten replicates

	Kappa Serum Free Light Chains		Lambda Serum Free Light Chains
	Mean SD (mg/L)	Coefficient of Variation (%)	Mean (SD) (mg/L)	Coefficient of Variation (%)
Within-batch	11.17 (1.09)	9.76	9.06 (0.69)	7.64
Between-batch	16.96 (1.21)	7.12	27.42 (1.92)	7.02

Latest news

16 March 2022

Causes and Diagnosis of Multiple Myeloma

07 March 2018

Early Findings from the iStopMM Project discussed by Dr Brian Durie, Dr Sigurdur Kristinsson and Dr Ste Harding on Facebook Live

17 January 2014

Swedish study confirms abnormal kappa lambda ratio predicts risk for progression of MGUS

See all news

Get in touch

Freelite aids the detection and monitoring of Multiple Myeloma and related diseases

Enquire Now